Research Tree provides access to ongoing research coverage, media content and regulatory news on Continental Chemicals Limited.
We currently have 0 research reports from 0
Companies: Cerillion Plc
Gresham has won an extension and expansion deal with a long-standing Tier 1 investment bank customer as it continues to standardise on the Clareti platform. Including this and other deals, current ARR rises to £23.3m, a 5% organic uplift from end June. Clareti/Electra are trading in line, though Gresham flags potential for further new business in FY21 and an “encouraging pipeline” for FY22. Non-Clareti revenues are performing ahead of expectations leading us to upgrade FY21 revenues and adj. EBI
Companies: Gresham Technologies plc
Adjusted EBITDA growth of +19% YoY in H1A reflects both higher margins and higher quality revenues. The Group now has 50%+ visibility over H2E revenues. This year will be second half weighted too but returning momentum post COVID-19 means the business is now in a much stronger position. Fair value lies in excess of twice the current price. Buy.
Companies: Shearwater Group plc
GB Group (GBG) has announced a conditional agreement to acquire Acuant, a leading player in the US identity verification market. At an enterprise value of £547m, it marks GBG’s largest acquisition to date. The deal strengthens GBG’s position in the US, broadens its product offering and accelerates its technology roadmap. We have revised our forecasts to reflect the placing and the acquisition and our normalised EPS forecasts decline 3% in FY22, are flat in FY23 and increase 3% in FY24.
Companies: GB Group PLC
tinyBuild announced the acquisition of Versus Evil, a publisher based in the US, and Red Cerberus, its development services subsidiary in Brazil. We estimate tinyBuild is paying only 5.4x 2022 EBITDA, based on upfront payment only and estimates that do not lead to earnout payments. We raise our 2022 EPS estimate by 10% (see overleaf). The acquisition provides tinyBuild with access to talent and IP in Latin America as well as in-house Quality Assurance, testing and localisation capabilities.
Companies: tinyBuild Inc.
Intercede has reported interims confirming performance in line with unchanged expectations. 9% revenue growth at constant currency (2% reported), as reported at the October trading update, remains on track with our 10% constant currency (5% reported) forecasts. EBITDA of £0.4m, compared with £0.6m EBITDA in 1H21, reflects the impact of pay rises, with the benefit of reduced interest charges post the CLN conversion doubling adjusted PBT from £0.1m to £0.2m. The five Cs (colleagues, customers, ch
Companies: Intercede Group plc
Finals to June 2021 are in line with the July TU, detailing the very strong performance which had led to upgraded expectations (+5% EBITDA, +7% adj PBT & adj dil EPS), and which are politely exceeded, with EBITDA ahead a further 3% and adj dil EPS +5%. Reinforcement of the strong balance sheet led to £32m y/e cash (no debt) after £8.8m free cash flow. The three strategic pillars each contributed, delivering increased ARPC +16%, from larger numbers of customers, 22% international revenue growth,
Companies: dotDigital Group plc
Intuit continued with its exceptional run and had a robust fourth quarter capping off an exceptional year. Their full-year revenue increased by a staggering 25%, including the addition of Credit Karma with the fourth quarter alone contributing $2.6 billion to the top-line. The biggest drivers of the top-line growth are the Consumer Group segment which grew by 16% and the Self-Employed Group which grew by around 14%. These have wonderfully complemented the company’s core QuickBooks Online offerin
Companies: INTUIT (INTU:NYSE)Intuit Inc. (INTU:NAS)
Arrow Exploration Corp. (AIM:AXL; TSXV:AXL), the high-growth operator with a portfolio of assets across key Colombian hydrocarbon basins, has joined AIM, alongside a fundraise of approximately £8.8m.
No Leavers Today
What’s cooking in the IPO kitchen?
ATOM headquartered in Leeds, focussed on the large-scale production of green hydrogen and ammonia intends to join AIM towards the end of the year. ATOME intends to be spun-out from AIM-listed President Energy Plc, an oil and gas com
Companies: SPA ECR KP2 SAR SYM
iEnergizer has reported interim results significantly ahead of expectations, supporting our view that the Group is entering a period of outsized growth and new business wins which will scale rapidly to the short and long term benefit of shareholders. With very attractive financial characteristics and inexpensive valuation, there are significant capital and income returns on offer. Buy
Companies: iEnergizer Limited
Companies: NCC Group plc
While the outcomes of COP26 are mixed, we think that the watering down of ambition on coal power is positive for negative emission technologies and the moves to phase-out fossil fuel subsidies potentially makes green hydrogen more competitive. Broader support for clean energy and efficiency helps and annual monitoring is likely to ensure that support develops to the benefit of the sector. Policy remains an essential part of the clean energy mix especially in its ability to create or mitigate inv
Companies: ADN DRX GSF ITM NESF PHE SAE SIT STRLNG TLG VLS
Bivictrix 26.5p £17.5m (BVX.L)
BiVictriX Therapeutics, an emerging biotechnology company applying a novel approach to develop next generation cancer therapies using insights derived from frontline clinical experience announced a collaboration to manufacture BiVictriX's antibody-drug conjugates with Abzena Limited, a partner research organisation for integrated discovery to cGMP manufacturing solutions for biologics. The collaboration will allow BiVictriX to cost-effectively manuf
Companies: CHRT CSSG CCS CYAN FIH MIRI YGEN